Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.96 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.94.
Market Cap
8.96T
Revenue
4.59T
Profits
199.3B
PE Ratio
44.94
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -0.64% | 2,717,520 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 611.38B | - | 6,511,902 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 443.57B | -0.23% | 6,982,663 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 387.36B | 2.62% | 4,979,673 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 309.64B | -2.44% | 10,454,427 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 285.33B | -3.04% | 2,114,955 | 60.44B |
| 7 | NVS | Novartis AG | 283.14B | -1.65% | 1,768,389 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 218.72B | 1.73% | 10,192,728 | 50.57B |
| 9 | AMGN | Amgen Inc. | 195.01B | -0.22% | 2,212,781 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 190.76B | 2.39% | 2,216,777 | 45.20B |
| 11 | ABT | Abbott Laboratories | 160.56B | 1.59% | 13,810,288 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.40B | -0.29% | 6,499,521 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 142.51B | 1.18% | 1,886,029 | 10.58B |
| 14 | DHR | Danaher Corporation | 137.11B | 1.70% | 4,515,554 | 24.78B |
| 15 | PFE | Pfizer Inc. | 136.10B | -0.83% | 49,331,406 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.73B | 1.31% | 7,434,812 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.40B | 0.26% | 937,860 | 12.22B |
| 18 | SYK | Stryker Corporation | 120.14B | -0.46% | 2,917,684 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 115.25B | -2.05% | 7,673,586 | 48.48B |
| 20 | GSK | GSK plc | 102.12B | -2.14% | 3,202,644 | 43.29B |
| 21 | MDT | Medtronic plc | 101.38B | 1.24% | 7,611,066 | 36.36B |
| 22 | SNY | Sanofi | 99.86B | -2.41% | 4,520,284 | 54.60B |
| 23 | ELV | Elevance Health, Inc. | 90.38B | 7.62% | 2,102,110 | 200.42B |
| 24 | MCK | McKesson Corporation | 89.92B | 1.65% | 1,143,913 | 403.43B |
| 25 | HCA | HCA Healthcare, Inc. | 87.24B | 0.86% | 1,171,254 | 76.39B |
| 26 | CI | The Cigna Group | 73.29B | 0.50% | 2,214,980 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 64.00B | 0.89% | 25,357,043 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.56B | 0.19% | 1,122,187 | 14.92B |
| 29 | ARGX | argenx SE | 56.21B | -1.97% | 370,077 | 4.74B |
| 30 | COR | Cencora, Inc. | 56.12B | 1.92% | 1,278,971 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 55.68B | 0.07% | 1,038,292 | 250.74B |
| 32 | MDLN | Medline Inc. | 54.82B | 5.81% | 12,161,013 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.97B | 1.69% | 4,253,260 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.10B | -0.50% | 2,169,561 | 28.34B |
| 35 | HUM | Humana Inc. | 49.16B | 3.07% | 1,685,093 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.41B | 2.12% | 647,123 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 42.13B | 1.04% | 2,115,962 | 22.23B |
| 38 | HLN | Haleon plc | 40.67B | 0.75% | 8,392,891 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.28B | 0.21% | 1,070,442 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.86B | 0.12% | 2,082,542 | - |
| 41 | NTRA | Natera, Inc. | 39.57B | 1.78% | 1,861,484 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.94B | -1.30% | 4,241,076 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.67B | 0.42% | 2,354,837 | 7.23B |
| 44 | WAT | Waters Corporation | 37.13B | 0.82% | 924,773 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 33.91B | 5.17% | 2,475,997 | 16.63B |
| 46 | CNC | Centene Corporation | 33.75B | 6.48% | 5,828,604 | 178.33B |
| 47 | ALC | Alcon Inc. | 32.45B | -0.42% | 2,766,436 | 10.63B |
| 48 | ONC | BeOne Medicines AG | 32.32B | 2.02% | 342,275 | 5.70B |
| 49 | RPRX | Royalty Pharma plc | 32.12B | -0.52% | 2,520,404 | 2.44B |
| 50 | BIIB | Biogen Inc. | 30.97B | -2.93% | 1,138,610 | 9.94B |
| 51 | ZTS | Zoetis Inc. | 30.37B | 0.82% | 6,267,414 | 9.53B |
| 52 | VEEV | Veeva Systems Inc. | 29.93B | 3.80% | 3,147,744 | 3.32B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 29.50B | 1.33% | 3,606,443 | 20.98B |
| 54 | RMD | ResMed Inc. | 29.04B | 3.19% | 1,111,975 | 5.54B |
| 55 | MRNA | Moderna, Inc. | 28.77B | 3.53% | 6,697,955 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 27.82B | 4.58% | 2,122,527 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 26.57B | 2.24% | 4,747,096 | 4.82B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.28B | 1.79% | 265,148 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 25.98B | 0.04% | 707,783 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.79B | 1.67% | 675,054 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.20B | -1.02% | 4,369,685 | 8.26M |
| 62 | DGX | Quest Diagnostics Incorporated | 23.91B | 1.92% | 682,207 | 11.28B |
| 63 | BNTX | BioNTech SE | 23.75B | 0.93% | 545,159 | 3.23B |
| 64 | LH | Labcorp Holdings Inc. | 23.28B | 1.39% | 719,516 | 14.14B |
| 65 | UTHR | United Therapeutics Corporation | 23.22B | 0.98% | 413,261 | 3.17B |
| 66 | INSM | Insmed Incorporated | 23.19B | 0.36% | 2,348,777 | 819.56M |
| 67 | INCY | Incyte Corporation | 22.74B | 0.40% | 1,224,588 | 5.36B |
| 68 | GH | Guardant Health, Inc. | 22.64B | 13.82% | 6,698,500 | 1.08B |
| 69 | STE | STERIS plc | 20.69B | 0.82% | 1,079,328 | 5.94B |
| 70 | VTRS | Viatris Inc. | 18.84B | 1.89% | 13,245,153 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.87B | -0.45% | 927,301 | 3.10B |
| 72 | GMAB | Genmab A/S | 16.84B | 0.62% | 1,448,431 | 3.90B |
| 73 | ASND | Ascendis Pharma A/S | 16.63B | 0.40% | 541,765 | 998.25M |
| 74 | THC | Tenet Healthcare Corporation | 16.47B | 2.20% | 1,066,292 | 21.46B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.28B | -2.23% | 2,543,030 | 8.41B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.52B | 2.64% | 271,347 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.90B | -1.44% | 873,152 | 4.44B |
| 78 | DVA | DaVita Inc. | 14.64B | 2.49% | 841,616 | 13.84B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.60B | 0.05% | 3,001,699 | 579.96M |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.55B | 0.16% | 3,413,867 | 13.65B |
| 81 | COO | The Cooper Companies, Inc. | 14.03B | 0.33% | 5,040,397 | 4.23B |
| 82 | SOLV | Solventum Corporation | 13.57B | 1.56% | 1,126,691 | 8.26B |
| 83 | EXEL | Exelixis, Inc. | 13.56B | -0.83% | 1,843,235 | 2.38B |
| 84 | ICLR | ICON Public Limited Company | 13.41B | 0.77% | 808,746 | 8.27B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 13.09B | -0.13% | 1,433,232 | 1.06B |
| 86 | ALGN | Align Technology, Inc. | 13.00B | 7.61% | 1,484,988 | 4.10B |
| 87 | RVTY | Revvity, Inc. | 12.59B | 1.42% | 1,424,082 | 2.90B |
| 88 | PEN | Penumbra, Inc. | 12.45B | 0.22% | 454,905 | 1.45B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.38B | -1.68% | 976,713 | 708.24M |
| 90 | SNN | Smith & Nephew plc | 12.33B | -0.28% | 2,144,246 | 6.16B |
| 91 | FMS | Fresenius Medical Care AG | 12.26B | 1.11% | 1,006,551 | 22.32B |
| 92 | MOH | Molina Healthcare, Inc. | 12.11B | 1.68% | 932,893 | 43.10B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.03B | -2.11% | 4,534,004 | 4.89B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.86B | -4.20% | 303,743 | 1.13B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.73B | -3.45% | 2,655,947 | 3.58B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.58B | 0.08% | 2,135,297 | 105.82M |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.33B | -1.31% | 1,975,591 | 622.01M |
| 98 | BAX | Baxter International Inc. | 11.20B | 1.74% | 6,495,367 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.18B | 1.07% | 1,484,980 | 3.24B |
| 100 | SMMT | Summit Therapeutics Inc. | 11.16B | -1.30% | 3,908,339 | - |
| 101 | PODD | Insulet Corporation | 11.07B | 4.95% | 1,555,689 | 2.90B |
| 102 | TECH | Bio-Techne Corporation | 11.06B | 0.50% | 11,029,770 | 1.21B |
| 103 | TEM | Tempus AI, Inc. | 11.06B | 6.34% | 8,969,836 | 1.36B |
| 104 | CRL | Charles River Laboratories International, Inc. | 11.03B | 1.01% | 1,084,740 | 4.03B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.95B | -0.02% | 296,574 | 417.30M |
| 106 | ABVX | ABIVAX Société Anonyme | 10.52B | -0.53% | 4,786,736 | 5.67M |
| 107 | GMED | Globus Medical, Inc. | 10.31B | -3.86% | 2,950,287 | 3.10B |
| 108 | EHC | Encompass Health Corporation | 10.06B | 0.31% | 558,937 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.03% | 3,710,448 | - |
| 110 | NUVL | Nuvalent, Inc. | 9.76B | 0.08% | 722,808 | - |
| 111 | IBRX | ImmunityBio, Inc. | 9.64B | 5.08% | 15,059,144 | 140.98M |
| 112 | HSIC | Henry Schein, Inc. | 9.63B | 1.20% | 1,018,464 | 13.38B |
| 113 | OSCR | Oscar Health, Inc. | 9.61B | 11.85% | 7,082,107 | 13.30B |
| 114 | ENSG | The Ensign Group, Inc. | 9.55B | 2.82% | 612,131 | 5.27B |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.50B | 1.76% | 1,045,440 | 769.10M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.39B | -0.33% | 895,303 | 51.48M |
| 117 | BRKR | Bruker Corporation | 9.23B | 0.76% | 2,414,969 | 3.46B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 9.13B | -1.61% | 1,742,845 | 1.51B |
| 119 | UHS | Universal Health Services, Inc. | 9.12B | 1.27% | 882,631 | 17.76B |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 8.91B | -4.54% | 609,342 | 7.46M |
| 121 | HIMS | Hims & Hers Health, Inc. | 8.70B | 8.36% | 27,983,144 | 2.37B |
| 122 | ALKS | Alkermes plc | 8.62B | -1.29% | 1,638,262 | 1.56B |
| 123 | PCVX | Vaxcyte, Inc. | 8.10B | -3.53% | 1,490,455 | - |
| 124 | QGEN | Qiagen N.V. | 8.09B | 0.08% | 2,840,393 | 2.10B |
| 125 | GKOS | Glaukos Corporation | 8.08B | -1.57% | 707,563 | 551.35M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 8.05B | 2.11% | 387,226 | 74.06M |
| 127 | ATR | AptarGroup, Inc. | 7.99B | 0.04% | 405,572 | 3.87B |
| 128 | BIO | Bio-Rad Laboratories, Inc. | 7.95B | 1.19% | 201,200 | 2.59B |
| 129 | RGEN | Repligen Corporation | 7.84B | 1.87% | 1,161,888 | 763.34M |
| 130 | IMVT | Immunovant, Inc. | 7.83B | -1.01% | 822,761 | - |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.72B | 0.12% | 1,682,236 | - |
| 132 | HQY | HealthEquity, Inc. | 7.72B | 2.21% | 1,193,661 | 1.34B |
| 133 | TGTX | TG Therapeutics, Inc. | 7.59B | -2.58% | 2,011,495 | 700.35M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.56B | -0.59% | 999,167 | 217.17M |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 7.35B | 2.90% | 1,012,604 | 569.61M |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.09B | -1.78% | 633,010 | 1.55B |
| 137 | LQDA | Liquidia Corporation | 7.05B | -0.51% | 1,310,271 | 288.07M |
| 138 | PACS | PACS Group, Inc. | 7.01B | 3.94% | 1,236,225 | 5.43B |
| 139 | AVTR | Avantor, Inc. | 6.83B | 1.11% | 10,705,041 | 6.55B |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.75B | -0.27% | 1,221,573 | 827.11M |
| 141 | HNGE | Hinge Health, Inc. | 6.58B | 2.49% | 1,979,542 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.58B | -0.57% | 2,007,368 | - |
| 143 | TWST | Twist Bioscience Corporation | 6.37B | -0.61% | 1,498,712 | 409.48M |
| 144 | CHE | Chemed Corporation | 6.36B | 3.25% | 175,678 | 2.54B |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.34B | -3.84% | 1,304,375 | - |
| 146 | CGON | CG Oncology, Inc. | 6.25B | -0.23% | 1,144,753 | 5.07M |
| 147 | GRFS | Grifols, S.A. | 6.18B | - | 1,098,017 | 8.58B |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.18B | -1.29% | 418,663 | 274.48M |
| 149 | BLCO | Bausch + Lomb Corporation | 5.90B | -0.06% | 399,485 | 5.21B |
| 150 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | -0.10% | 1,271,447 | 7.50M |
| 151 | LEGN | Legend Biotech Corporation | 5.78B | 3.50% | 1,611,779 | 1.14B |
| 152 | DFTX | Definium Therapeutics, Inc. | 5.76B | -7.74% | 3,110,312 | - |
| 153 | TFX | Teleflex Incorporated | 5.74B | 2.36% | 427,229 | 2.13B |
| 154 | BLLN | BillionToOne, Inc. | 5.63B | 1.96% | 686,972 | 354.54M |
| 155 | ORKA | Oruka Therapeutics, Inc. | 5.63B | -1.98% | 1,483,549 | - |
| 156 | BLTE | Belite Bio, Inc | 5.60B | -7.58% | 250,018 | - |
| 157 | ERAS | Erasca, Inc. | 5.57B | -2.18% | 3,287,867 | - |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.41B | -1.96% | 1,315,583 | 3.05B |
| 159 | MANE | Veradermics, Incorporated | 5.37B | 4.51% | 737,474 | - |
| 160 | CRSP | CRISPR Therapeutics AG | 5.36B | 1.98% | 964,121 | 4.10M |
| 161 | CAI | Caris Life Sciences, Inc. | 5.30B | 5.22% | 4,166,790 | 907.29M |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.24B | -0.83% | 1,147,111 | 536.20M |
| 163 | RDNT | RadNet, Inc. | 5.16B | 6.41% | 1,008,191 | 2.14B |
| 164 | CELC | Celcuity Inc. | 5.10B | -0.12% | 1,098,112 | - |
| 165 | SHC | Sotera Health Company | 5.06B | - | 2,530,359 | 1.19B |
| 166 | STVN | Stevanato Group S.p.A. | 5.01B | 1.49% | 231,756 | 1.39B |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.96B | 0.84% | 3,572,016 | 4.26B |
| 168 | TXG | 10x Genomics, Inc. | 4.96B | 1.85% | 3,255,893 | 638.78M |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | -7.46% | 1,613,544 | 1.34M |
| 170 | INDV | Indivior Pharmaceuticals, Inc. | 4.91B | -1.90% | 1,478,140 | 1.29B |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.84B | -1.67% | 679,937 | 754.05M |
| 172 | VCYT | Veracyte, Inc. | 4.78B | 1.91% | 1,229,796 | 541.74M |
| 173 | LIVN | LivaNova PLC | 4.53B | 0.30% | 475,126 | 1.43B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.43B | 6.72% | 4,946,730 | 1.49B |
| 175 | NVST | Envista Holdings Corporation | 4.42B | 3.11% | 3,159,031 | 2.81B |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.35B | -3.92% | 3,104,342 | - |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.32B | -0.40% | 1,416,598 | 1.10B |
| 178 | MMED | MiniMed Group, Inc. | 4.27B | 1.61% | 859,710 | 3.10B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.21B | -3.61% | 1,278,044 | - |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.16B | -8.09% | 4,360,847 | 56.99M |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.14B | 0.16% | 768,591 | 1.54B |
| 182 | DNLI | Denali Therapeutics Inc. | 4.12B | 1.05% | 1,200,675 | - |
| 183 | NAMS | NewAmsterdam Pharma Company N.V. | 4.11B | 3.78% | 894,819 | 22.57M |
| 184 | WAY | Waystar Holding Corp. | 4.11B | 4.38% | 2,736,029 | 1.16B |
| 185 | IRTC | iRhythm Holdings, Inc. | 4.09B | 4.69% | 628,296 | 787.85M |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.08B | 3.34% | 1,165,765 | 18.07M |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.99B | 2.69% | 155,599 | 803.79M |
| 188 | RGC | Regencell Bioscience Holdings Limited | 3.98B | 31.86% | 2,539,990 | - |
| 189 | DOCS | Doximity, Inc. | 3.95B | 4.10% | 3,586,596 | 644.86M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.94B | 3.43% | 2,191,252 | 2.23B |
| 191 | RLAY | Relay Therapeutics, Inc. | 3.87B | -5.08% | 3,360,711 | 10.68M |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 815,950 | 596.96M |
| 193 | BKD | Brookdale Senior Living Inc. | 3.78B | -1.68% | 3,188,528 | 3.00B |
| 194 | ICUI | ICU Medical, Inc. | 3.71B | 1.27% | 239,724 | 2.16B |
| 195 | GPCR | Structure Therapeutics Inc. | 3.70B | -2.89% | 1,511,991 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.64B | -6.20% | 1,605,036 | 236.00M |
| 197 | DYN | Dyne Therapeutics, Inc. | 3.61B | -1.80% | 1,383,757 | - |
| 198 | WRBY | Warby Parker Inc. | 3.60B | -3.20% | 2,921,791 | 890.57M |
| 199 | ADPT | Adaptive Biotechnologies Corporation | 3.58B | 4.29% | 3,362,022 | 295.41M |
| 200 | OGN | Organon & Co. | 3.55B | -0.07% | 2,124,506 | 6.16B |
| 201 | PBLS | Parabilis Medicines, Inc. | 3.54B | 1.50% | 596,336 | - |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | -2.95% | 1,016,624 | 225.27M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.40B | -3.92% | 1,125,056 | - |
| 204 | HAE | Haemonetics Corporation | 3.40B | -0.20% | 636,815 | 1.33B |
| 205 | ALMS | Alumis Inc. | 3.40B | -5.33% | 1,209,687 | 8.40M |
| 206 | PRVA | Privia Health Group, Inc. | 3.39B | 4.47% | 1,204,886 | 2.25B |
| 207 | BEAM | Beam Therapeutics Inc. | 3.33B | -2.45% | 1,977,586 | 164.01M |
| 208 | NHC | National HealthCare Corporation | 3.32B | 0.64% | 99,034 | 1.53B |
| 209 | OPCH | Option Care Health, Inc. | 3.30B | 0.33% | 2,215,811 | 5.67B |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -1.45% | 672,204 | 415.62M |
| 211 | ITGR | Integer Holdings Corporation | 3.21B | 1.20% | 398,583 | 1.86B |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | 3.18B | -3.02% | 2,635,795 | 670.00M |
| 213 | QURE | uniQure N.V. | 3.11B | -1.93% | 965,771 | 18.09M |
| 214 | VERA | Vera Therapeutics, Inc. | 3.06B | -0.58% | 1,074,557 | - |
| 215 | GRAL | GRAIL, Inc. | 2.92B | -0.23% | 489,012 | 156.12M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.89B | -1.16% | 483,164 | 865.00K |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.87B | 5.82% | 3,496,449 | 3.37B |
| 218 | IRON | Disc Medicine, Inc. | 2.86B | 2.47% | 1,334,069 | - |
| 219 | CLOV | Clover Health Investments, Corp. | 2.84B | 2.86% | 7,993,244 | 2.21B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | 1.94% | 902,155 | 776.83M |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.70B | -5.49% | 1,329,231 | - |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.67B | 0.62% | 772,894 | 1.46B |
| 223 | MBX | MBX Biosciences, Inc. | 2.66B | 1.30% | 967,794 | - |
| 224 | HTFL | HeartFlow, Inc. | 2.65B | 4.67% | 2,020,428 | 191.42M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.63B | 3.99% | 1,233,852 | 229.58M |
| 226 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | -3.26% | 2,924,690 | 535.08M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.50B | -5.63% | 3,050,807 | - |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.47B | -1.44% | 968,991 | 71.78M |
| 229 | ASTH | Astrana Health, Inc. | 2.47B | 7.33% | 1,700,467 | 3.53B |
| 230 | SLS | SELLAS Life Sciences Group, Inc. | 2.47B | -10.09% | 10,811,867 | - |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.45B | -3.50% | 4,866,221 | 885.72M |
| 232 | IMNM | Immunome, Inc. | 2.43B | 1.42% | 2,029,152 | 4.02M |
| 233 | NTLA | Intellia Therapeutics, Inc. | 2.41B | 1.89% | 3,726,770 | 66.09M |
| 234 | BHVN | Biohaven Ltd. | 2.37B | 5.91% | 4,367,495 | - |
| 235 | PHVS | Pharvaris N.V. | 2.37B | -1.82% | 376,128 | - |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -0.33% | 1,363,693 | - |
| 237 | TMDX | TransMedics Group, Inc. | 2.34B | 2.15% | 1,050,576 | 635.89M |
| 238 | AXGN | Axogen, Inc. | 2.34B | -4.70% | 999,246 | 238.11M |
| 239 | KOD | Kodiak Sciences Inc. | 2.33B | -4.41% | 742,427 | - |
| 240 | ABCL | AbCellera Biologics Inc. | 2.32B | -3.18% | 7,608,444 | 79.21M |
| 241 | PGNY | Progyny, Inc. | 2.31B | 2.12% | 1,498,812 | 1.29B |
| 242 | VCEL | Vericel Corporation | 2.31B | 1.48% | 613,538 | 292.09M |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 1.88% | 538,135 | 1.09B |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.26B | 2.97% | 556,101 | 256.28M |
| 245 | XRAY | DENTSPLY SIRONA Inc. | 2.22B | 4.52% | 5,169,268 | 3.68B |
| 246 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | -0.08% | 967,843 | 66.05M |
| 247 | NKTR | Nektar Therapeutics | 2.18B | -7.76% | 1,216,065 | 55.63M |
| 248 | KARD | Kardigan, Inc. | 2.15B | 1.09% | 1,239,044 | - |
| 249 | ZLAB | Zai Lab Limited | 2.15B | 0.79% | 686,357 | 453.28M |
| 250 | SGRY | Surgery Partners, Inc. | 2.15B | -1.22% | 1,121,615 | 3.34B |
| 251 | WGS | GeneDx Holdings Corp. | 2.13B | 4.46% | 721,408 | 442.68M |
| 252 | TSHA | Taysha Gene Therapies, Inc. | 2.13B | -2.35% | 2,641,367 | 7.47M |
| 253 | GENB | Generate Biomedicines, Inc. | 2.12B | -2.19% | 963,496 | 30.30M |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.10B | 3.20% | 753,942 | 1.93B |
| 255 | UFPT | UFP Technologies, Inc. | 2.08B | 1.60% | 185,046 | 608.85M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | -1.14% | 793,293 | 899.11M |
| 257 | BFLY | Butterfly Network, Inc. | 2.07B | -5.82% | 8,035,446 | 102.92M |
| 258 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -3.56% | 2,180,252 | 52.04M |
| 259 | SEM | Select Medical Holdings Corporation | 2.05B | - | - | 5.52B |
| 260 | VRDN | Viridian Therapeutics, Inc. | 2.04B | 0.60% | 2,718,497 | 70.92M |
| 261 | STOK | Stoke Therapeutics, Inc. | 2.04B | -0.03% | 1,071,424 | 32.08M |
| 262 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -6.89% | 2,042,503 | 298.30M |
| 263 | GLUE | Monte Rosa Therapeutics, Inc. | 2.03B | -0.74% | 1,127,183 | 42.95M |
| 264 | NEOG | Neogen Corporation | 2.03B | 3.56% | 1,669,593 | 870.56M |
| 265 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | -0.06% | 1,531,029 | -665.00K |
| 266 | ADMA | ADMA Biologics, Inc. | 2.00B | 2.87% | 3,038,749 | 509.86M |
| 267 | PVLA | Palvella Therapeutics, Inc. | 1.98B | -9.63% | 468,612 | - |
| 268 | PLSE | Pulse Biosciences, Inc. | 1.97B | 2.76% | 228,940 | 751.00K |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.95B | -1.30% | 293,714 | 1.20B |
| 270 | NEO | NeoGenomics, Inc. | 1.95B | 2.60% | 3,228,295 | 745.97M |
| 271 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | - | 35,684,611 | 66.41M |
| 272 | SNDA | Sonida Senior Living, Inc. | 1.95B | 2.28% | 844,548 | 367.34M |
| 273 | AVAH | Aveanna Healthcare Holdings Inc. | 1.93B | 3.38% | 1,407,251 | 2.52B |
| 274 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 1.28% | 3,425,385 | 2.18B |
| 275 | NBTX | Nanobiotix S.A. | 1.92B | 5.15% | 77,270 | 38.27M |
| 276 | OMCL | Omnicell, Inc. | 1.91B | 0.99% | 505,399 | 1.23B |
| 277 | ANAB | AnaptysBio, Inc. | 1.90B | -3.07% | 698,041 | 232.39M |
| 278 | BCAX | Bicara Therapeutics Inc. | 1.90B | -2.63% | 891,733 | - |
| 279 | NUVB | Nuvation Bio Inc. | 1.89B | -4.58% | 8,350,641 | 143.05M |
| 280 | RAPP | Rapport Therapeutics, Inc. | 1.88B | -5.47% | 251,740 | 20.00M |
| 281 | ABSI | Absci Corporation | 1.88B | -4.14% | 5,077,419 | 1.84M |
| 282 | SION | Sionna Therapeutics, Inc. | 1.88B | -5.34% | 391,968 | - |
| 283 | ZYME | Zymeworks Inc. | 1.88B | -1.61% | 462,943 | 81.26M |
| 284 | PGEN | Precigen, Inc. | 1.87B | -7.89% | 7,445,797 | 31.60M |
| 285 | ADUS | Addus HomeCare Corporation | 1.87B | 1.77% | 292,007 | 1.45B |
| 286 | AGL | agilon health, inc. | 1.86B | 4.25% | 311,883 | 5.82B |
| 287 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -4.44% | 2,168,784 | 217.17M |
| 288 | URGN | UroGen Pharma Ltd. | 1.85B | 3.10% | 970,608 | 140.49M |
| 289 | TRLV | Trulieve Cannabis Corp. | 1.83B | -2.95% | 683,358 | 1.17B |
| 290 | HCM | HUTCHMED (China) Limited | 1.83B | 0.19% | 93,811 | 548.51M |
| 291 | MESO | Mesoblast Limited | 1.83B | 4.14% | 245,446 | 65.38M |
| 292 | NVCR | NovoCure Limited | 1.83B | 4.16% | 1,350,492 | 674.41M |
| 293 | GHRS | GH Research PLC | 1.81B | -1.71% | 185,944 | - |
| 294 | ALMR | Alamar Biosciences, Inc. | 1.81B | -3.54% | 838,819 | 87.16M |
| 295 | ATAI | AtaiBeckley Inc. | 1.80B | -7.40% | 8,207,980 | 3.49M |
| 296 | CMPS | COMPASS Pathways plc | 1.79B | -6.08% | 4,230,722 | - |
| 297 | BHC | Bausch Health Companies Inc. | 1.78B | -3.25% | 2,445,258 | 10.53B |
| 298 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | -4.57% | 21,350,933 | 285.61M |
| 299 | ZBIO | Zenas BioPharma, Inc. | 1.77B | 10.32% | 2,484,009 | 10.00M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 0.33% | 254,842 | 923.71M |
| 301 | TYRA | Tyra Biosciences, Inc. | 1.75B | -7.73% | 752,034 | - |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.72B | 2.24% | 547,296 | 1.85B |
| 303 | AKTS | Aktis Oncology, Inc. | 1.71B | -4.16% | 534,721 | 8.28M |
| 304 | DMRA | Damora Therapeutics, Inc. | 1.67B | 4.34% | 580,920 | - |
| 305 | FTRE | Fortrea Holdings Inc. | 1.66B | 1.03% | 1,574,425 | 2.71B |
| 306 | MAZE | Maze Therapeutics, Inc. | 1.65B | -0.10% | 1,090,901 | 20.00M |
| 307 | TDOC | Teladoc Health, Inc. | 1.64B | 7.31% | 5,812,250 | 2.51B |
| 308 | MPLT | MapLight Therapeutics, Inc. | 1.64B | 0.67% | 504,701 | - |
| 309 | INVA | Innoviva, Inc. | 1.62B | -3.57% | 468,008 | 420.69M |
| 310 | VIR | Vir Biotechnology, Inc. | 1.61B | -6.18% | 1,905,073 | 65.50M |
| 311 | IMCR | Immunocore Holdings plc | 1.61B | -0.35% | 824,228 | 412.81M |
| 312 | AVBP | ArriVent BioPharma, Inc. | 1.61B | -0.69% | 314,762 | - |
| 313 | HROW | Harrow, Inc. | 1.60B | 1.25% | 633,539 | 268.68M |
| 314 | INNV | InnovAge Holding Corp. | 1.59B | -1.18% | 464,761 | 949.17M |
| 315 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.59B | -1.44% | 2,234,640 | 204.73M |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.58B | -1.75% | 1,118,900 | - |
| 317 | SEPN | Septerna, Inc. | 1.56B | 3.34% | 377,632 | 72.26M |
| 318 | AAPG | Ascentage Pharma Group International | 1.56B | 2.33% | 14,855 | 82.08M |
| 319 | NVAX | Novavax, Inc. | 1.56B | 0.42% | 4,565,930 | 596.34M |
| 320 | SVRA | Savara Inc. | 1.54B | -1.62% | 1,511,886 | - |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.53B | 3.30% | 757,094 | 83.72M |
| 322 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | -11.52% | 228,771 | - |
| 323 | CDNA | CareDx, Inc. | 1.51B | 2.63% | 726,718 | 412.82M |
| 324 | ATRC | AtriCure, Inc. | 1.50B | 6.04% | 1,088,256 | 552.16M |
| 325 | ARDT | Ardent Health, Inc. | 1.45B | 2.95% | 625,384 | 6.43B |
| 326 | PSNL | Personalis, Inc. | 1.44B | 2.91% | 3,965,937 | 64.52M |
| 327 | PRGO | Perrigo Company plc | 1.43B | -0.77% | 5,438,289 | 4.18B |
| 328 | AHCO | AdaptHealth Corp. | 1.41B | 1.73% | 1,461,101 | 3.29B |
| 329 | STAA | STAAR Surgical Company | 1.40B | -1.88% | 361,181 | 290.38M |
| 330 | INBX | Inhibrx Biosciences, Inc. | 1.39B | 0.17% | 296,971 | 1.30M |
| 331 | BLFS | BioLife Solutions, Inc. | 1.39B | 0.89% | 778,500 | 101.66M |
| 332 | IART | Integra LifeSciences Holdings Corporation | 1.39B | -0.39% | 803,323 | 1.64B |
| 333 | XERS | Xeris Biopharma Holdings, Inc. | 1.38B | 1.01% | 2,435,130 | 314.85M |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.36B | 2.43% | 3,360,488 | 787.08M |
| 335 | IMTX | Immatics N.V. | 1.35B | -2.76% | 229,992 | 43.00M |
| 336 | OMDA | Omada Health, Inc. | 1.34B | 3.05% | 1,286,156 | 283.30M |
| 337 | AVLN | Avalyn Pharma Inc. | 1.34B | -8.25% | 785,445 | - |
| 338 | CAPR | Capricor Therapeutics, Inc. | 1.34B | -4.19% | 1,807,130 | 11.13M |
| 339 | PRCT | PROCEPT BioRobotics Corporation | 1.34B | 3.94% | 1,349,453 | 322.02M |
| 340 | NUTX | Nutex Health Inc. | 1.31B | 11.60% | 215,044 | 879.95M |
| 341 | INSP | Inspire Medical Systems, Inc. | 1.31B | 1.91% | 1,348,585 | 915.25M |
| 342 | PAHC | Phibro Animal Health Corporation | 1.30B | 2.23% | 420,127 | 1.50B |
| 343 | PNTG | The Pennant Group, Inc. | 1.30B | 1.11% | 386,825 | 1.02B |
| 344 | JBIO | Jade Biosciences, Inc. | 1.29B | -1.85% | 632,577 | - |
| 345 | AHG | Akso Health Group | 1.29B | 1.34% | 17,472 | 14.84M |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.29B | 2.69% | 577,171 | 3.42B |
| 347 | ARDX | Ardelyx, Inc. | 1.27B | 1.18% | 5,228,621 | 427.68M |
| 348 | IRMD | IRADIMED CORPORATION | 1.25B | 2.56% | 154,809 | 86.28M |
| 349 | MNKD | MannKind Corporation | 1.25B | -4.93% | 2,721,233 | 360.78M |
| 350 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -1.24% | 2,088,061 | - |
| 351 | QDEL | QuidelOrtho Corporation | 1.24B | 3.80% | 1,536,502 | 2.66B |
| 352 | SDGR | Schrödinger, Inc. | 1.22B | 0.86% | 2,049,930 | 254.91M |
| 353 | ALVO | Alvotech | 1.21B | -2.98% | 882,867 | 562.04M |
| 354 | AZTA | Azenta, Inc. | 1.21B | 2.63% | 641,910 | 596.48M |
| 355 | MGTX | MeiraGTx Holdings plc | 1.19B | -5.26% | 1,382,995 | 79.76M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -0.91% | 405,876 | 796.33M |
| 357 | OPK | OPKO Health, Inc. | 1.16B | 2.00% | 2,587,823 | 581.12M |
| 358 | ENOV | Enovis Corporation | 1.15B | -3.19% | 1,502,683 | 2.28B |
| 359 | AVNS | Avanos Medical, Inc. | 1.15B | -1.00% | 1,551,114 | 715.90M |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -1.24% | 245,787 | - |
| 361 | AORT | Artivion, Inc. | 1.14B | 4.81% | 671,371 | 458.69M |
| 362 | XNCR | Xencor, Inc. | 1.14B | -4.47% | 1,015,914 | 97.36M |
| 363 | DRTS | Alpha Tau Medical Ltd. | 1.14B | 0.48% | 1,103,667 | - |
| 364 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.55% | 1,386,870 | - |
| 365 | WVE | Wave Life Sciences Ltd. | 1.12B | 0.52% | 3,150,199 | 71.80M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | 2.93% | 574,993 | 1.03B |
| 367 | EYPT | EyePoint, Inc. | 1.11B | -7.73% | 2,151,539 | 7.61M |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.09B | 3.83% | 175,027 | 787.69M |
| 369 | BIOA | BioAge Labs, Inc. | 1.08B | -0.86% | 657,653 | 10.32M |
| 370 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | 4.41% | 1,312,740 | 1.03B |
| 371 | SANA | Sana Biotechnology, Inc. | 1.07B | 2.01% | 2,875,611 | - |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 1.06B | -5.11% | 637,234 | - |
| 373 | OLMA | Olema Pharmaceuticals, Inc. | 1.06B | -3.44% | 2,354,122 | - |
| 374 | CERT | Certara, Inc. | 1.05B | 2.75% | 3,661,666 | 419.75M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | -2.50% | 2,408,609 | 69.64M |
| 376 | GDRX | GoodRx Holdings, Inc. | 1.04B | 6.25% | 2,063,302 | 787.89M |
| 377 | EVO | Evotec SE | 1.03B | 1.79% | 35,478 | 859.03M |
| 378 | CRON | Cronos Group Inc. | 1.03B | 2.88% | 1,423,941 | 159.54M |
| 379 | SLDB | Solid Biosciences Inc. | 1.00B | 2.10% | 2,033,893 | - |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 1.00B | 1.19% | 393,354 | 86.93M |
| 381 | VOR | Vor Biopharma Inc. | 996.48M | -0.11% | 1,386,607 | - |
| 382 | CNMD | CONMED Corporation | 986.38M | 0.09% | 396,695 | 1.37B |
| 383 | PCRX | Pacira BioSciences, Inc. | 984.88M | -1.34% | 559,346 | 734.86M |
| 384 | AVR | Anteris Technologies Global Corp. | 967.58M | 0.91% | 2,203,125 | 1.85M |
| 385 | PHAR | Pharming Group N.V. | 964.46M | -1.69% | 4,552 | 369.49M |
| 386 | KURA | Kura Oncology, Inc. | 956.99M | -1.73% | 2,086,035 | 71.64M |
| 387 | DBVT | DBV Technologies S.A. | 953.36M | -4.09% | 266,202 | 5.74M |
| 388 | REPL | Replimune Group, Inc. | 941.86M | 1.36% | 2,975,610 | - |
| 389 | ABUS | Arbutus Biopharma Corporation | 934.35M | -1.46% | 2,768,051 | 191.45M |
| 390 | INMD | InMode Ltd. | 930.11M | 0.41% | 526,301 | 374.64M |
| 391 | DSGN | Design Therapeutics, Inc. | 915.62M | 1.31% | 1,103,679 | - |
| 392 | LBRX | LB Pharmaceuticals Inc | 914.93M | -1.69% | 216,181 | - |
| 393 | ANNX | Annexon, Inc. | 909.33M | -2.80% | 4,919,719 | - |
| 394 | AVTX | Avalo Therapeutics, Inc. | 908.86M | -6.44% | 1,850,498 | 59.00K |
| 395 | JANX | Janux Therapeutics, Inc. | 894.03M | -4.56% | 1,360,709 | 13.73M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 887.15M | -0.30% | 422,006 | 720.53M |
| 397 | TBPH | Theravance Biopharma, Inc. | 875.37M | -0.12% | 1,198,136 | 109.78M |
| 398 | ANRO | Alto Neuroscience, Inc. | 875.24M | -5.49% | 378,166 | - |
| 399 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 2,590,060 | 238.37M |
| 400 | IVA | Inventiva S.A. | 854.43M | -2.38% | 1,713,427 | 7.94M |
| 401 | PHAT | Phathom Pharmaceuticals, Inc. | 837.19M | -2.86% | 910,864 | 204.89M |
| 402 | HSTM | HealthStream, Inc. | 826.21M | 3.78% | 220,144 | 311.78M |
| 403 | BVS | Bioventus Inc. | 822.82M | 4.34% | 674,878 | 576.30M |
| 404 | OCS | Oculis Holding AG | 817.05M | -2.45% | 419,282 | 1.40M |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 816.38M | -3.70% | 1,107,434 | 122.29M |
| 406 | GERN | Geron Corporation | 814.73M | -0.78% | 9,906,530 | 196.12M |
| 407 | ESPR | Esperion Therapeutics, Inc. | 813.48M | - | 5,149,994 | 418.24M |
| 408 | GMRS | GMR Solutions Inc. | 797.21M | -4.53% | 1,266,102 | 5.83B |
| 409 | ODTX | Odyssey Therapeutics, Inc. | 790.47M | -11.76% | 375,259 | 1.06M |
| 410 | SSII | SS Innovations International, Inc. | 788.52M | -5.06% | 92,547 | 48.47M |
| 411 | SPRY | ARS Pharmaceuticals, Inc. | 788.47M | -0.87% | 1,148,590 | 98.99M |
| 412 | CTMX | CytomX Therapeutics, Inc. | 783.73M | -4.00% | 6,423,753 | 35.54M |
| 413 | CLYM | Climb Bio, Inc. | 764.14M | 2.34% | 1,912,335 | - |
| 414 | CBLL | CeriBell, Inc. | 758.85M | 2.83% | 322,776 | 95.07M |
| 415 | CSTL | Castle Biosciences, Inc. | 749.45M | 3.61% | 198,873 | 339.92M |
| 416 | ACRS | Aclaris Therapeutics, Inc. | 745.80M | 0.95% | 2,167,194 | 8.37M |
| 417 | SIBN | SI-BONE, Inc. | 745.07M | 2.94% | 564,746 | 206.22M |
| 418 | BBNX | Beta Bionics, Inc. | 744.18M | 6.57% | 787,161 | 110.24M |
| 419 | AURA | Aura Biosciences, Inc. | 742.32M | -5.21% | 680,107 | - |
| 420 | ALLO | Allogene Therapeutics, Inc. | 728.28M | 1.44% | 12,335,653 | 22.00K |
| 421 | CADL | Candel Therapeutics, Inc. | 723.91M | -4.08% | 1,749,416 | - |
| 422 | SLBT | SL Science Holding Limited | 719.23M | -7.10% | 262,922 | - |
| 423 | RIGL | Rigel Pharmaceuticals, Inc. | 708.44M | -2.12% | 218,342 | 299.77M |
| 424 | DRUG | Bright Minds Biosciences Inc. | 704.76M | -5.21% | 576,303 | - |
| 425 | PRME | Prime Medicine, Inc. | 702.60M | 5.42% | 3,788,364 | 4.03M |
| 426 | IMMX | Immix Biopharma, Inc. | 699.80M | -4.66% | 1,559,704 | - |
| 427 | TCMD | Tactile Systems Technology, Inc. | 691.35M | 2.92% | 161,391 | 343.52M |
| 428 | OMER | Omeros Corporation | 681.05M | -1.05% | 1,428,937 | 9.89M |
| 429 | TENX | Tenax Therapeutics, Inc. | 679.01M | -8.66% | 746,039 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 678.21M | -2.14% | 1,652,176 | 361.51M |
| 431 | RGNX | REGENXBIO Inc. | 676.72M | 9.27% | 4,456,449 | 87.82M |
| 432 | DNA | Ginkgo Bioworks Holdings, Inc. | 671.54M | 3.73% | 1,452,890 | 151.40M |
| 433 | RLMD | Relmada Therapeutics, Inc. | 670.25M | -7.66% | 2,142,923 | - |
| 434 | CRMD | CorMedix Inc. | 664.49M | 7.90% | 1,276,307 | 400.05M |
| 435 | FDMT | 4D Molecular Therapeutics, Inc. | 663.39M | -4.59% | 1,073,687 | 88.24M |
| 436 | EIKN | Eikon Therapeutics, Inc. | 663.20M | -6.13% | 608,545 | - |
| 437 | PHR | Phreesia, Inc. | 662.62M | 4.18% | 695,208 | 495.59M |
| 438 | ACHV | Achieve Life Sciences, Inc. | 657.02M | -1.99% | 3,840,140 | - |
| 439 | SGP | SpyGlass Pharma, Inc. | 653.79M | -12.15% | 94,232 | - |
| 440 | TRAX | First Tracks Biotherapeutics, Inc. | 648.65M | -7.46% | 468,641 | - |
| 441 | EVH | Evolent Health, Inc. | 645.64M | 5.90% | 2,390,968 | 1.89B |
| 442 | MNPR | Monopar Therapeutics Inc. | 636.58M | 2.64% | 177,431 | - |
| 443 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 624.03M | 2.23% | 479,384 | - |
| 444 | TECX | Tectonic Therapeutic, Inc. | 620.23M | -4.38% | 231,655 | - |
| 445 | BWAY | BrainsWay Ltd. | 618.30M | -1.42% | 58,707 | 56.22M |
| 446 | ALT | Altimmune, Inc. | 612.59M | 3.62% | 7,484,167 | 36.00K |
| 447 | FTH | Faeth Therapeutics, Inc. | 601.81M | -6.62% | 114,310 | - |
| 448 | CERS | Cerus Corporation | 601.11M | 2.74% | 4,908,268 | 216.56M |
| 449 | GYRE | Gyre Therapeutics, Inc. | 598.03M | -0.68% | 82,303 | 117.05M |
| 450 | FLGT | Fulgent Genetics, Inc. | 591.58M | 1.51% | 307,387 | 320.35M |
| 451 | CTKB | Cytek Biosciences, Inc. | 591.47M | 3.27% | 1,177,849 | 204.17M |
| 452 | AGMB | AgomAb Therapeutics NV | 584.57M | -8.55% | 166,652 | - |
| 453 | MDXG | MiMedx Group, Inc. | 580.89M | 1.30% | 716,448 | 389.42M |
| 454 | PROK | ProKidney Corp. | 570.89M | -7.35% | 1,382,001 | 889.00K |
| 455 | CTNM | Contineum Therapeutics, Inc. | 569.77M | -7.02% | 319,303 | - |
| 456 | CBIO | Crescent Biopharma, Inc. | 567.55M | -5.11% | 179,598 | 11.88M |
| 457 | MYGN | Myriad Genetics, Inc. | 566.69M | 5.08% | 1,625,967 | 829.00M |
| 458 | CLPT | ClearPoint Neuro, Inc. | 561.40M | 4.93% | 470,808 | 40.61M |
| 459 | CTEV | Claritev Corporation | 552.35M | -5.01% | 84,212 | 978.76M |
| 460 | TOI | The Oncology Institute, Inc. | 550.91M | 1.47% | 1,541,290 | 545.76M |
| 461 | ANGO | AngioDynamics, Inc. | 544.79M | 0.46% | 357,657 | 313.73M |
| 462 | NNNN | Anbio Biotechnology | 541.84M | -9.96% | 34,741 | 8.65M |
| 463 | PACB | Pacific Biosciences of California, Inc. | 540.45M | 3.57% | 5,001,976 | 160.03M |
| 464 | NPCE | NeuroPace, Inc. | 537.66M | -0.76% | 188,165 | 99.53M |
| 465 | NGNE | Neurogene Inc. | 535.37M | 7.73% | 566,503 | 925.00K |
| 466 | XOMA | XOMA Royalty Corporation | 534.50M | 0.28% | 124,640 | 48.56M |
| 467 | AQST | Aquestive Therapeutics, Inc. | 531.91M | 1.92% | 1,261,655 | 50.27M |
| 468 | ASMB | Assembly Biosciences, Inc. | 529.52M | -2.77% | 204,110 | 71.10M |
| 469 | ARVN | Arvinas, Inc. | 529.07M | -1.32% | 761,709 | 89.40M |
| 470 | TLRY | Tilray Brands, Inc. | 528.42M | -1.34% | 4,196,235 | 858.28M |
| 471 | FBRX | Forte Biosciences, Inc. | 519.50M | 0.05% | 339,474 | - |
| 472 | NVCT | Nuvectis Pharma, Inc. | 517.78M | 6.14% | 899,305 | - |
| 473 | RZLT | Rezolute, Inc. | 517.11M | -4.81% | 2,427,629 | - |
| 474 | KYTX | Kyverna Therapeutics, Inc. | 513.11M | -5.27% | 803,290 | - |
| 475 | WEAV | Weave Communications, Inc. | 510.02M | 7.01% | 1,147,965 | 248.72M |
| 476 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 477 | EDIT | Editas Medicine, Inc. | 503.35M | 1.23% | 2,982,309 | 38.69M |
| 478 | NRC | NRC Health | 501.89M | 3.25% | 136,814 | 138.64M |
| 479 | PRTA | Prothena Corporation plc | 501.54M | -2.15% | 435,333 | 57.94M |
| 480 | STRO | Sutro Biopharma, Inc. | 501.09M | -8.92% | 473,955 | 99.61M |
| 481 | OCGN | Ocugen, Inc. | 501.01M | -3.27% | 5,782,084 | 4.47M |
| 482 | OVID | Ovid Therapeutics Inc. | 500.20M | -0.37% | 1,412,766 | 7.12M |
| 483 | STTK | Shattuck Labs, Inc. | 499.19M | -6.20% | 1,985,411 | 1.00M |
| 484 | SLN | Silence Therapeutics plc | 495.96M | -4.37% | 718,986 | 839.00K |
| 485 | KIDS | OrthoPediatrics Corp. | 495.72M | 0.89% | 145,310 | 243.30M |
| 486 | CABA | Cabaletta Bio, Inc. | 487.53M | -3.86% | 5,449,137 | - |
| 487 | PRLD | Prelude Therapeutics Incorporated | 486.96M | -7.88% | 519,813 | 16.72M |
| 488 | VALN | Valneva SE | 485.57M | -2.68% | 21,042 | 180.25M |
| 489 | CCCC | C4 Therapeutics, Inc. | 479.86M | -7.07% | 5,113,275 | 34.86M |
| 490 | CYH | Community Health Systems, Inc. | 479.50M | 5.99% | 1,289,518 | 12.29B |
| 491 | ARTV | Artiva Biotherapeutics, Inc. | 476.16M | 1.03% | 512,443 | 251.00K |
| 492 | ZURA | Zura Bio Limited | 475.46M | -15.17% | 1,683,656 | - |
| 493 | SOPH | SOPHiA GENETICS SA | 468.97M | -3.12% | 427,097 | 81.18M |
| 494 | EVMN | Evommune, Inc. | 461.76M | -3.54% | 1,459,739 | 10.00M |
| 495 | SGMT | Sagimet Biosciences Inc. | 460.67M | -3.49% | 1,266,233 | - |
| 496 | SRTA | Strata Critical Medical, Inc. | 456.86M | 0.19% | 1,106,647 | 228.58M |
| 497 | VMD | Viemed Healthcare, Inc. | 450.07M | 2.98% | 249,493 | 286.57M |
| 498 | VREX | Varex Imaging Corporation | 449.49M | 2.25% | 416,244 | 857.50M |
| 499 | DCTH | Delcath Systems, Inc. | 445.67M | 2.54% | 318,558 | 90.44M |
| 500 | EOLS | Evolus, Inc. | 443.86M | -2.88% | 567,581 | 301.79M |